SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-012071
Filing Date
2023-04-06
Accepted
2023-04-06 16:10:31
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A eliem-defa14a-2023_proxy.htm DEFA14A 19483
2 GRAPHIC img32512924_0.jpg GRAPHIC 612973
3 GRAPHIC img32512924_1.jpg GRAPHIC 160726
  Complete submission text file 0000950170-23-012071.txt   1086062
Mailing Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053
Business Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053 877-354-3689
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40708 | Film No.: 23806274
SIC: 2834 Pharmaceutical Preparations